Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115574) titled 'Advanced Image-Guided Metastasis-Directed Therapy in Oligometastatic Prostate Cancer' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Naval Medical University
Condition:
Oligometastatic prostate cancer
Intervention:
Metastasis-directed therapy group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-12-30
Target Sample Size: Metastasis-directed therapy group:144;Standard of care group:206;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpr...